Entering text into the input field will update the search result below

Abbott Q1 top line up 17%; non-GAAP earnings up 25%

Apr. 18, 2018 11:59 AM ETAbbott Laboratories (ABT) StockBy: Douglas W. House, SA News Editor6 Comments
  • Abbott (NYSE:ABT -2.5%) Q1 results ($M): Total revenues: 7,390 (+16.7%).
  • Medical Devices: 2,744 (+14.6%); Diagnostics: 1,837 (+58.7%); Nutrition: 1,756 (+7.0%); Pharmaceuticals: 1,044 (+9.9%).
  • Net Income: 418 (-0.2%); non-GAAP net income (continuing ops): 1,050 (+24.6%); EPS: 0.23 (-4.2%); non-GAAP EPS: 0.59 (+22.9%).
  • Shares are under modest pressure in apparent response to its slight miss of 7.0% organic sales growth consensus (6.9%). Non-GAAP earnings and total revenue beat consensus.
  • Shares were up over 3% before reversing.

Recommended For You

About ABT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ABT--
Abbott Laboratories